FDA Approves First Treatment for Common Type of Post-Transplant Infection that is Resistant to Other DrugsNovember 23, 2021
FDA Approves First Drug to Improve Growth in Children with Most Common Form of DwarfismNovember 19, 2021
FDA In Brief: FDA Issues Final Orders Reclassifying Certain Hepatitis C Diagnostic Tests from Class III to Class IINovember 19, 2021
Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine BoostersNovember 19, 2021
FDA In Brief: FDA Announces Investigation of E. coli O157:H7 Outbreak Linked to SpinachNovember 16, 2021
Coronavirus (COVID-19) Update: FDA Updates Test Policies to Help to Ensure Accuracy and Reliability of Tests and Increase Access to At-Home TestsNovember 15, 2021
FDA Provides Update on Recall of Certain Philips Respironics Breathing Assistance MachinesNovember 12, 2021
FDA In Brief: FDA Provides New Draft Guidance on Premarket Submissions for Device Software FunctionsNovember 3, 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of AgeOctober 29, 2021
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseasesOctober 27, 2021
FDA In Brief: FDA Collaborates with Health Canada and UK’s MHRA to Foster Good Machine Learning PracticeOctober 27, 2021
